Loading…
Based on limited metadata, Somalabs, Inc. received an FDA Warning Letter on May 31, 2019, regarding dietary supplement products. Without access to the full letter text or subject line, the specific nature of the violations cannot be determined from the available information. The warning falls under FDA's dietary supplement regulatory authority, though the issuing office and exact violation count are not specified in this metadata.